← Open Payments lookup

LACEY ROSINSKI: Open Payments

NPI 1689230096 · PERU, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$384 in 20 payments from 10 companies in 2025. Trend: 2023 $94 · 2024 $751 · 2025 $384

Food & beverage: $384
CompanyPaymentsAmount
Lundbeck LLC4$86
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$60
Gilead Sciences, Inc.2$46
ABBVIE INC.3$46
Novo Nordisk Inc2$39
AstraZeneca Pharmaceuticals LP2$35
GlaxoSmithKline, LLC.1$31
Xeris Pharmaceuticals, Inc.1$16
Lilly USA, LLC1$16
Phathom Pharmaceuticals, Inc.1$7

Products named: REXULTI, CAPLYTA, QULIPTA, TRELEGY ELLIPTA, Ozempic, AIRSUPRA, KEVEYIS, MOUNJARO.

Industry payments across IN — which companies pay providers there.